Evidence map›Paper›PMID 33480466›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation.

Brian I Shaw, Hui-Jie Lee, Cliburn Chan, Robert Ettenger, Paul Grimm, Meghan Pearl, Elaine F Reed, Mark A Robien, Minnie Sarwal, Linda Stempora and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Anti-thymocyte globulin-resistant CD4Blood science (Baltimore, Md.) · 2026
    Article
  2. Article
  3. Association of T Cell Subsets and Platelet/Lymphocyte Ratio with Long-Term Complications in Kidney Transplant Recipients.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Brian I ShawDepartment of Surgery, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-2317-6549
Hui-Jie LeeDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Cliburn ChanDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Robert EttengerDepartment of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Paul GrimmDepartment of Pediatrics, Stanford University, Stanford, California, USA.
Meghan PearlDepartment of Pediatrics, University of California Los Angeles, Los Angeles, California, USA.
Elaine F ReedDepartment of Pathology, University of California, Los Angeles, California, USA.ORCID 0000-0002-3524-545X
Mark A RobienNational Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
Minnie SarwalDepartment of Surgery, University of California, San Francisco, California, USA.
Linda StemporaDepartment of Surgery, Duke University, Durham, North Carolina, USA.
Barry WarshawDepartment of Pediatrics, Children's Healthcare Atlanta, Atlanta, Georgia, USA.
Congwen ZhaoDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Olivia M MartinezDepartment of Surgery, Stanford University, Stanford, California, USA.
Allan D KirkDepartment of Surgery, Duke University, Durham, North Carolina, USA.
Eileen T ChambersDepartment of Surgery, Duke University, Durham, North Carolina, USA.ORCID 0000-0001-7060-9311
Duke University · USUniversity of California, Los Angeles · USStanford University · USChildren's Healthcare of Atlanta · USNational Institutes of Health · USUniversity of California, San Francisco · US

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
Development of Transplant Strategies Uniquely Responsive to the Needs of ChildrenU01AI077821 · NIAID · EMORY UNIVERSITY · PI KIRK, ALLAN D. · 2008 to 2012
$7.5M
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant RecipientsU01AI135947 · NIAID · STANFORD UNIVERSITY · PI MARTINEZ, OLIVIA M · 2018 to 2021
$3.6M
National Center for Advancing Translational Sciences of the National Institutes of Health UL1TR002553NCATS NIH HHS UL1 TR002553NIAID NIH HHS U01 AI077821NIAID NIH HHS U01 AI135947
6 · The paper itself

Abstract

Depletional induction using antithymocyte globulin (ATG) reduces rates of acute rejection in adult kidney transplant recipients, yet little is known about its effects in children. Using a longitudinal cohort of 103 patients in the Immune Development in Pediatric Transplant (IMPACT) study, we compared T cell phenotypes after ATG or non-ATG induction. We examined the effects of ATG on the early clinical outcomes of alloimmune events (development of de novo donor specific antibody and/or biopsy proven rejection) and infection events (viremia/viral infections). Long-term patient and graft outcomes were examined using the Scientific Registry of Transplant Recipients. After ATG induction, although absolute counts of CD4 and CD8 T cells were lower, patients had higher percentages of CD4 and CD8 memory T cells with a concomitant decrease in frequency of naïve T cells compared to non-ATG induction. In adjusted and unadjusted models, ATG induction was associated with increased early event-free survival, with no difference in long-term patient or allograft survival. Decreased CD4

Indexed as

Antilymphocyte SerumKidney TransplantationAdultChildGraft RejectionGraft SurvivalHumansImmunosuppressive AgentsPhenotypeAntilymphocyte SerumImmunosuppressive Agentsclinical research/practiceimmune regulationimmunosuppressant - polyclonal preparations: rabbit antithymocyte globulinimmunosuppression/immune modulationkidney transplantation/nephrologypediatricstranslational research/science

Identifiers

PMID33480466
PMCPMC7952017
OpenAlexW3049353196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.